Cipher Pharmaceuticals Inc.
TSX:CPH.TO
15.55 (CAD) • At close October 30, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Cipher Pharmaceuticals Inc. |
Symbool | CPH.TO |
Munteenheid | CAD |
Prijs | 15.55 |
Beurswaarde | 397,907,395 |
Dividendpercentage | 0% |
52-weken bereik | 4.3 - 19.69 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Craig J. Mull |
Website | https://www.cipherpharma.com |
An error occurred while fetching data.
Over Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. Its commercial products include Epuris (CIP-ISOTRETINOIN), a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; Ozenoxacin to treat adult and paediatric patients with impetigo; Actikerall, which is indicated for the treatment of palpable
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (CAD)
Cijfers zijn in miljoenen (CAD)